ArticleCommunications biology2026

cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment.

Ran Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.